211 related articles for article (PubMed ID: 30340922)
1. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.
Zhou TY; Zhou YL; Qian MJ; Fang YZ; Ye S; Xin WX; Yang XC; Wu HH
J Pharmacol Sci; 2018 Oct; 138(2):89-95. PubMed ID: 30340922
[TBL] [Abstract][Full Text] [Related]
2. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization.
Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z
Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.
Zhou TY; Zhuang LH; Hu Y; Zhou YL; Lin WK; Wang DD; Wan ZQ; Chang LL; Chen Y; Ying MD; Chen ZB; Ye S; Lou JS; He QJ; Zhu H; Yang B
Sci Rep; 2016 Aug; 6():30483. PubMed ID: 27476430
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
6. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
Yang J; Xing Z
Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
[TBL] [Abstract][Full Text] [Related]
7. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.
Bai N; Zhang C; Liang N; Zhang Z; Chang A; Yin J; Li Z; Luo N; Tan X; Luo N; Luo Y; Xiang R; Li X; Reisfeld RA; Stupack D; Lv D; Liu C
Cancer Biol Ther; 2013 Jun; 14(6):511-20. PubMed ID: 23760493
[TBL] [Abstract][Full Text] [Related]
10. MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10.
Li L; Sun P; Zhang C; Li Z; Zhou W
Biochimie; 2018 Jul; 150():23-30. PubMed ID: 29702181
[TBL] [Abstract][Full Text] [Related]
11. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
[TBL] [Abstract][Full Text] [Related]
12. Macrophages as Targets in Hepatocellular Carcinoma Therapy.
Liu YT; Mao ZW; Ding Y; Wang WL
Mol Cancer Ther; 2024 Jun; 23(6):780-790. PubMed ID: 38310642
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
[TBL] [Abstract][Full Text] [Related]
14. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
15. SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.
Li Z; Li H; Zhao ZB; Zhu W; Feng PP; Zhu XW; Gong JP
J Exp Clin Cancer Res; 2019 Nov; 38(1):469. PubMed ID: 31744516
[TBL] [Abstract][Full Text] [Related]
16. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
[TBL] [Abstract][Full Text] [Related]
17. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
18. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.
Capece D; Fischietti M; Verzella D; Gaggiano A; Cicciarelli G; Tessitore A; Zazzeroni F; Alesse E
Biomed Res Int; 2013; 2013():187204. PubMed ID: 23533994
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
Bao D; Zhao J; Zhou X; Yang Q; Chen Y; Zhu J; Yuan P; Yang J; Qin T; Wan S; Xing J
Oncogene; 2019 Jun; 38(25):5007-5020. PubMed ID: 30894684
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.
Shirabe K; Mano Y; Muto J; Matono R; Motomura T; Toshima T; Takeishi K; Uchiyama H; Yoshizumi T; Taketomi A; Morita M; Tsujitani S; Sakaguchi Y; Maehara Y
Surg Today; 2012 Jan; 42(1):1-7. PubMed ID: 22116397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
